Immunotherapy has emerged in recent years as a new cancer treatment that is gentler than traditional chemotherapy and causes milder side eff
Immunotherapy has emerged in recent years as a new cancer treatment that is gentler than traditional chemotherapy and causes milder side effects in patients. However, conventional dendritic cell (DC) immunotherapy shows inconsistent clinical outcomes, and the cell culture process remains complex and costly. A research team at The Education University of Hong Kong (EdUHK) has successfully developed a new silica-based nanostructured biomaterial, nanozigzags (NZs), that can significantly shorten the DC culture time, reduce production costs, and enhance therapeutic efficacy by nearly 70%. The work is published in the journal Advanced Materials.
Continue Reading.
